BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16092675)

  • 1. [Clinical usefulness of the ImmunoCyt urinary test in the follow-up protocol of patients with urothelial neoplasms].
    García Peñalver C; Pérez Barrios A; Leiva Galvis O
    Actas Urol Esp; 2005 Jun; 29(6):535-41. PubMed ID: 16092675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
    Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A
    Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
    Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ImmunoCyt--a new urine test in diagnosis of bladder cancer].
    Feil G; Bichler KH; Päulgen-Nelde HJ; Hennenlotter J; Zumbrägel A; Stenzl A
    Urologe A; 2003 Apr; 42(4):531-7. PubMed ID: 12715125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.
    Lodde M; Mian C; Comploj E; Palermo S; Longhi E; Marberger M; Pycha A
    Urology; 2006 May; 67(5):950-4. PubMed ID: 16698355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
    Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses.
    Mian C; Maier K; Comploj E; Lodde M; Berner L; Lusuardi L; Palermo S; Vittadello F; Pycha A
    Cancer; 2006 Feb; 108(1):60-5. PubMed ID: 16411183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
    Odisho AY; Berry AB; Ahmad AE; Cooperberg MR; Carroll PR; Konety BR
    Eur Urol; 2013 May; 63(5):936-40. PubMed ID: 22521093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.
    Toma MI; Friedrich MG; Hautmann SH; Jäkel KT; Erbersdobler A; Hellstern A; Huland H
    World J Urol; 2004 Jun; 22(2):145-9. PubMed ID: 14991320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
    Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
    Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States.
    Messing EM; Teot L; Korman H; Underhill E; Barker E; Stork B; Qian J; Bostwick DG
    J Urol; 2005 Oct; 174(4 Pt 1):1238-41. PubMed ID: 16145377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of urine-based tumour markers in bladder cancer surveillance.
    Horstmann M; Patschan O; Hennenlotter J; Senger E; Feil G; Stenzl A
    Scand J Urol Nephrol; 2009; 43(6):461-6. PubMed ID: 19903092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence.
    Vriesema JL; Atsma F; Kiemeney LA; Peelen WP; Witjes JA; Schalken JA
    Urology; 2001 Sep; 58(3):367-71. PubMed ID: 11549482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.
    Mowatt G; Zhu S; Kilonzo M; Boachie C; Fraser C; Griffiths TR; N'Dow J; Nabi G; Cook J; Vale L
    Health Technol Assess; 2010 Jan; 14(4):1-331, iii-iv. PubMed ID: 20082749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
    Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
    Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma.
    Olsson H; Zackrisson B
    Scand J Urol Nephrol; 2001 Sep; 35(4):280-2. PubMed ID: 11676352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma.
    Têtu B; Tiguert R; Harel F; Fradet Y
    Mod Pathol; 2005 Jan; 18(1):83-9. PubMed ID: 15389253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of urinary NMP-22 combined with urine cytology in follow-up surveillance of recurring superficial bladder urothelial carcinoma.
    Mansoor I; Calam RR; Al-Khafaji B
    Anal Quant Cytol Histol; 2008 Feb; 30(1):25-32. PubMed ID: 18459584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.